As an investor looking to invest in Canopy Growth shares, you need to be sure of how best to go about it. That is why this article explores the shares and answers several questions you may be having concerning this market. This post will give more insights into whether Canopy Shares are a good investment, why it’s dropping, the upcoming marijuana share to invest in, the outlook of Canopy shares as well as how you can buy them.
Is canopy growth stocks a good investment?
Unfortunately, no matter how executives tighten up Canopy’s strategies, the company keeps losing money in the growing industry, especially with uptight rules and regulations. The situation is even worse since the economy is currently shaken by the coronavirus pandemic.
According to IBD’s benchmarks, a Canopy stock is not a very good investment. However, investors who are willing to take risks and are eager to venture into marijuana stock can invest in Canopy stocks. They can do this purely depending on its chart pattern when it features a buy zone, although the shares are under the 22.29 entry.
IBD’s research suggests that investors would be in a better financial position if they invested in stocks with strong fundamentals and close to their highs. Besides, they advise investors to purchase stocks only after they rise beyond certain resistance levels known as buy points and set up on the correct bases. Experts argue that if a stock breaks past a buy point like that after shaking out skeptical investors, it means there is a long run higher ahead.
Since May, Canopy has been in a consolidation pattern with a buy point of 22.29. According to MarketSmith, CGC stock has a 33 composite rating of a possible best 99. Research proves that the largest stock winners have composite ratings of 90s. Canopy’s relative strength line, which compares with Canopy’s stock presentation to the S&P 500, dropped at the end of May. The line has weakened greatly since then. Canopy’s stock growth is under the 200-day and 50-day lines.
Why did canopy growth-share drop today?
Shares of several cannabis companies like the Canopy Growth Corporation are trading low according to Aurora Cannabis NYSE ACB fourth-quarter earnings result. The report shows a decline in sales in the cannabis industry in comparison to previous years. As of 23rd September 2020, around noon, the Canopy stock was trading below 6.7% at $14.98 with a 52-week high of $25.97 and a fifty-two-week low of $9.
There were some instances when the Canadian weed stocks had soared, like when investors hoped that the United States election results could improve the cannabis market. They forgot that what the market gives it can easily take away. At the time, NYSE CGC share was 5.5%.
Volatility is not a new thing in stocks. This is especially true with the big Canadian stocks from cannabis producers, which have not been profitable on a steady basis. Such volatility reflects even without new developments for particular stocks. Investors should focus on the long-term growth and ignore the daily price swings on shares of cannabis.
Legalization of marijuana in the United States, even if it’s only for medical reasons, would greatly improve the cannabis market. Unfortunately, cannabis companies cannot utilize this opportunity to the maximum and expand territories into the U.S. market. Canopy Growth has a larger pile of stocks compared to companies like Tilray and Aurora. The stockpile can be attributed to the equity investments made to the company by Constellation. Besides, the company is already in a position to enter the U.S. cannabis market, incase federal laws change.
Relaxation of U.S. federal laws in cannabis could greatly contribute to Aurora, Tilray and Canopy’s success in the future. However, the three companies are currently focusing on the Canadian cannabis market. Although the COVID-19 pandemic has brought some challenges in the Canadian market, the cannabis 2.0 market derivative has expanded and opened new cannabis companies’ growth opportunities.
There are several development factors for financiers to keep an eye on in the next three months with the cannabis stocks. Maybe the main development is the upcoming U.S election in November. The results of the U.S Senate and presidential elections between Trump and Joe Biden hold a possible change in the three cannabis companies’ fortunes.
The companies are expected to provide a quarterly basis report very soon. Tilray and Canopy presented their latest updates in August, so they should announce the next results in November. On the other hand, Aurora provided its updates in September, so it should provide the next report at least a month after Canopy and Tilray.
Investors should also watch out for the covid-19 impact, especially if lockdowns will be re-stated in Canada. The lockdown could affect all the three top cannabis producers causing a huge financial loss.
The Marijuana shares that investors have been waiting for
A small, unpopular Canadian company unraveled what some experts feel would be the key to unlocking a marijuana boom. Investors should be keen on this as it’s truly on the way. Over the last few years, 11 states, including Washington D.C, legalized marijuana for recreational purposes. The full legalization in Canada occurred in October 2018, sweeping across the entire North America.
One unnoticed Canadian company is expected to shine in this anticipated revolution after a game-changing deal happened between this company and the Ontario government.
What is the outlook for canopy growth?
Analysts giving an outlook on canopy growth share price have a 17.79 median target. The high and low estimates are 23.00 and 13.50, respectively. This median estimate reflects a -5.40% decrease from the previous price of 18.80. Canopy shares are expected to increase in value with time, although this is not assured. Investors looking to venture into them should analyze the market and be ready to take risks before making their investments.
How do I buy shares in canopy growth?
It’s quite easy to buy Canopy stock, especially if you already have an account with a respectable online stockbroker. Pilot your broker’s order entry or trading platform and enter the number of CGC shares you want to buy with the price you are buying.
You can either limit your order to a day’s trading session or leave it open with your broker. Alternatively, you can buy shares Canopy shares at the market or wait for it to reach your desired level before entering an order. How you purchase the shares is equally important to where you trade them, so pick the right broker to minimize uncertainties in the bear market. Here is a guide on how to go about it.
- Pick a broker: different brokers offer different services, so be sure of your needs first before making a choice. For instance, brokers like TD Ameritrade and Charles Schwab are the best for beginners with limited market experience.
- Try various demo accounts: luckily, a good number of online brokers of their clients free virtual or demo accounts. With a demo account, traders can test and practice different trades in a risk-free environment. You can open as many as possible demo accounts and practice buying shares from Canopy before settling on the best broker.
- Fund your account: whether you settle on a premium or a commission-free broker, you must fund your trading account for you to purchase Canopy shares. Depending on your broker, your deposit requirements may vary, so make sure to check with your broker to learn the minimum and maximum deposit you can make.
- Buy the Canopy shares: once you open and fund your account, you are ready to buy shares. You can now start trading and join other millionaire makers.
I believe this post was helpful, so feel free to share it via your social media platforms and feel free to leave a comment down below.
Disclaimer: This article is not investment advice or an investment recommendation and should not be considered as such. The information above is not an invitation to trade and it does not guarantee or predict future performance. The investor is solely responsible for the risk of their decisions. The analysis and commentary presented do not include any consideration of your personal investment objectives, financial circumstances or needs.
Risk Warning: Our products are traded on margin and carry a high level of risk and it is possible to lose all your capital. These products may not be suitable for everyone and you should ensure that you understand the risks involved.